These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30296786)

  • 1. Structure-Activity Relationship of the GPR55 Antagonist, CID16020046.
    Brown AJ; Castellano-Pellicena I; Haslam CP; Nichols PL; Dowell SJ
    Pharmacology; 2018; 102(5-6):324-331. PubMed ID: 30296786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function.
    Kargl J; Brown AJ; Andersen L; Dorn G; Schicho R; Waldhoer M; Heinemann A
    J Pharmacol Exp Ther; 2013 Jul; 346(1):54-66. PubMed ID: 23639801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis.
    Kargl J; Andersen L; Hasenöhrl C; Feuersinger D; Stančić A; Fauland A; Magnes C; El-Heliebi A; Lax S; Uranitsch S; Haybaeck J; Heinemann A; Schicho R
    Br J Pharmacol; 2016 Jan; 173(1):142-54. PubMed ID: 26436760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The GPR55 antagonist CID16020046 protects against intestinal inflammation.
    Stančić A; Jandl K; Hasenöhrl C; Reichmann F; Marsche G; Schuligoi R; Heinemann A; Storr M; Schicho R
    Neurogastroenterol Motil; 2015 Oct; 27(10):1432-45. PubMed ID: 26227635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression.
    Lee SJ; Im DS
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of l-alpha-lysophosphatidylinositol-induced relaxation in human pulmonary arteries.
    Karpińska O; Baranowska-Kuczko M; Malinowska B; Kloza M; Kusaczuk M; Gęgotek A; Golec P; Kasacka I; Kozłowska H
    Life Sci; 2018 Jan; 192():38-45. PubMed ID: 29155298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The GPR55 antagonist CID16020046 mitigates advanced glycation end products (AGEs)- induced chondrocyte activation.
    Zeng Y; Liu Z; Tan X; Lei L
    Chem Biol Interact; 2020 Jul; 325():109088. PubMed ID: 32360554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible role of hippocampal GPR55 in spatial learning and memory in rats.
    Marichal-Cancino BA; Fajardo-Valdez A; Ruiz-Contreras AE; Méndez-Díaz M; Prospéro-García O
    Acta Neurobiol Exp (Wars); 2018; 78(1):41-50. PubMed ID: 29694340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive Effects of the GPR55 Antagonist CID16020046 Injected into the Rat Anterior Cingulate Cortex.
    Okine BN; Mc Laughlin G; Gaspar JC; Harhen B; Roche M; Finn DP
    Neuroscience; 2020 Sep; 443():19-29. PubMed ID: 32673629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The LPI/GPR55 axis enhances human breast cancer cell migration via HBXIP and p-MLC signaling.
    Zhou XL; Guo X; Song YP; Zhu CY; Zou W
    Acta Pharmacol Sin; 2018 Mar; 39(3):459-471. PubMed ID: 29188802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intra-striatal administration of GPR55 agonist (LPI) and antagonist (ML193) on sensorimotor and motor functions in a Parkinson's disease rat model.
    Fatemi I; Abdollahi A; Shamsizadeh A; Allahtavakoli M; Roohbakhsh A
    Acta Neuropsychiatr; 2021 Feb; 33(1):15-21. PubMed ID: 32967746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GPR55 Antagonist CID16020046 Attenuates Obesity-Induced Airway Inflammation by Suppressing Chronic Low-Grade Inflammation in the Lungs.
    Son SE; Lee YJ; Shin YJ; Kim DH; Im DS
    Int J Mol Sci; 2024 Jul; 25(13):. PubMed ID: 39000464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-1602 Promotes Hepatic Steatosis through GPR55 and PI3 Kinase/Akt/SREBP-1c Signaling in Mice.
    Kang S; Lee AY; Park SY; Liu KH; Im DS
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity.
    Hurst K; Badgley C; Ellsworth T; Bell S; Friend L; Prince B; Welch J; Cowan Z; Williamson R; Lyon C; Anderson B; Poole B; Christensen M; McNeil M; Call J; Edwards JG
    Hippocampus; 2017 Sep; 27(9):985-998. PubMed ID: 28653801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GPR55 antagonist CID16020046 protects against ox-LDL-induced inflammation in human aortic endothelial cells (HAECs).
    Wang Y; Pan W; Wang Y; Yin Y
    Arch Biochem Biophys; 2020 Mar; 681():108254. PubMed ID: 31904362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presynaptic nigral GPR55 receptors stimulate [
    Sánchez-Zavaleta R; Ávalos-Fuentes JA; González-Hernández AV; Recillas-Morales S; Paz-Bermúdez FJ; Leyva-Gómez G; Cortés H; Florán B
    Synapse; 2022 Sep; 76(11-12):e22246. PubMed ID: 35831708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis.
    Montecucco F; Bondarenko AI; Lenglet S; Burger F; Piscitelli F; Carbone F; Roth A; Liberale L; Dallegri F; Brandt KJ; Fraga-Silva RA; Stergiopulos N; Di Marzo V; Mach F
    Thromb Haemost; 2016 Oct; 116(5):987-997. PubMed ID: 27465665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CID16020046, a GPR55 antagonist, attenuates sepsis‑induced acute kidney injury.
    Chen R; Xu H; Guo Z; Zhang P; Chen J; Chen Z
    Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35244189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scotopic vision in the monkey is modulated by the G protein-coupled receptor 55.
    Bouskila J; Harrar V; Javadi P; Casanova C; Hirabayashi Y; Matsuo I; Ohyama J; Bouchard JF; Ptito M
    Vis Neurosci; 2016 Jan; 33():E006. PubMed ID: 27485069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligands.
    Kotsikorou E; Sharir H; Shore DM; Hurst DP; Lynch DL; Madrigal KE; Heynen-Genel S; Milan LB; Chung TD; Seltzman HH; Bai Y; Caron MG; Barak LS; Croatt MP; Abood ME; Reggio PH
    Biochemistry; 2013 Dec; 52(52):9456-69. PubMed ID: 24274581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.